Ann Surg
- WU CA, Ho I, Minasian A, Keuroghlian AS, et al
Variability in Medicaid Coverage for Gender-affirming Surgeries Across U.S.
States.
Ann Surg. 2024;279:542-548.
Ann Surg Oncol
- KLASSEN CL, Viers LD, Ghosh K
Following the High-Risk Patient: Breast Cancer Risk-Based Screening.
Ann Surg Oncol. 2024 Feb 1. doi: 10.1245/s10434-024-14957.
- CHOI S, Borowsky PA, Morgan O, Kwon D, et al
A Multi-institutional Analysis of Factors Influencing the Rate of Positive MRI
Biopsy Among Women with Early-Stage Breast Cancer.
Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14954.
- NG TP, Loo BYK, Yong N, Chia CLK, et al
Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A
Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing
Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
Ann Surg Oncol. 2024 Jan 29. doi: 10.1245/s10434-024-14943.
Anticancer Res
- DODDI S, Hibshman T, Salichs O, Tirumani SH, et al
Disparities in Mortality Trends of Breast Cancer by Racial and Ethnic Status in
the United States.
Anticancer Res. 2024;44:751-755.
BMC Cancer
- WEAVER KE, Dressler EV, Smith S, Nightingale CL, et al
Cardiovascular health assessment in routine cancer follow-up in community
settings: survivor risk awareness and perspectives.
BMC Cancer. 2024;24:158.
- ZHANG Y, Guan Y, Zheng X, Li C, et al
Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in
breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling
pathway.
BMC Cancer. 2024;24:167.
- GOLESTAN A, Tahmasebi A, Maghsoodi N, Faraji SN, et al
Unveiling promising breast cancer biomarkers: an integrative approach combining
bioinformatics analysis and experimental verification.
BMC Cancer. 2024;24:155.
- BELAID I, Baya MF, Ben Ayed S, Ben Ayed A, et al
Transcutaneous canine breast cancer detection in Tunisia: a pilot study.
BMC Cancer. 2024;24:151.
Br J Cancer
- HOLT S, Verrill M, Pettit L, Rigg A, et al
A UK prospective multicentre decision impact, decision conflict and economic
evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve,
HER2-ve breast cancer.
Br J Cancer. 2024 Feb 2. doi: 10.1038/s41416-024-02588.
- GAILLARD T, Piketty J, Feron JG, Girard N, et al
Rethinking surgical revisions: impact of the MonarchE trial on axillary
dissection in hormone-positive HER2-negative early breast cancer patients
potentially eligible for abemaciclib.
Br J Cancer. 2024 Jan 27. doi: 10.1038/s41416-024-02580.
Breast Cancer
- ZHENG H, Wu L, Chen J, Na N, et al
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of
triple-negative breast cancer in humanized mouse models.
Breast Cancer. 2024 Jan 30. doi: 10.1007/s12282-024-01543.
Breast Cancer (Auckl)
- CHAI T, Yue W, Xu P, Gildea J, et al
Caveolin-1, a Determinant of the Fate of MCF-7 Breast Cancer Cells.
Breast Cancer (Auckl). 2024;18:11782234241226802.
Breast Cancer Res
- SHARMA A, Weitz P, Wang Y, Liu B, et al
Development and prognostic validation of a three-level NHG-like deep
learning-based model for histological grading of breast cancer.
Breast Cancer Res. 2024;26:17.
- HAN X, Guo Y, Ye H, Chen Z, et al
Development of a machine learning-based radiomics signature for estimating breast
cancer TME phenotypes and predicting anti-PD-1/PD-L1 immunotherapy response.
Breast Cancer Res. 2024;26:18.
- NIE J, Dang S, Zhu R, Lu T, et al
ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher
risk of HER2-positive mammary tumorigenesis and metastasis.
Breast Cancer Res. 2024;26:19.
- LYNCE F, Stevens LE, Li Z, Brock JE, et al
TBCRC 039: a phase II study of preoperative ruxolitinib with or without
paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res. 2024;26:20.
Breast Cancer Res Treat
- JOHANSSON H, Bellerba F, Macis D, Bertelsen BE, et al
Effect of metformin and lifestyle intervention on adipokines and hormones in
breast cancer survivors: a pooled analysis from two randomized controlled trials.
Breast Cancer Res Treat. 2024 Jan 26. doi: 10.1007/s10549-023-07241.
- LEE IH, Lee SJ, Kang B, Lee J, et al
Exploration of MELK as a downstream of Del-1 and druggable targets in
triple-negative breast cancer.
Breast Cancer Res Treat. 2024 Jan 27. doi: 10.1007/s10549-023-07198.
- PRATHIBHA S, White M, Kolbow M, Hui JYC, et al
Omission of axillary lymph node dissection for breast cancer patients with three
or more positive sentinel lymph nodes.
Breast Cancer Res Treat. 2024 Jan 28. doi: 10.1007/s10549-023-07203.
- NAAKTGEBOREN WR, Koevoets EW, Stuiver MM, van Harten WH, et al
Effects of physical exercise during adjuvant chemotherapy for breast cancer on
long-term tested and perceived cognition: results of a pragmatic follow-up study.
Breast Cancer Res Treat. 2024 Jan 29. doi: 10.1007/s10549-023-07220.
- WOOD SJ, Gao Y, Lee JH, Chen J, et al
High tumor infiltrating lymphocytes are significantly associated with
pathological complete response in triple negative breast cancer treated with
neoadjuvant KEYNOTE-522 chemoimmunotherapy.
Breast Cancer Res Treat. 2024 Jan 30. doi: 10.1007/s10549-023-07233.
- VERSCHOOR N, Bos MK, de Kruijff IE, Van MN, et al
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer
patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a
phase II trial.
Breast Cancer Res Treat. 2024 Jan 31. doi: 10.1007/s10549-023-07231.
- ZHU E, Zhang L, Wang J, Hu C, et al
Deep learning-guided adjuvant chemotherapy selection for elderly patients with
breast cancer.
Breast Cancer Res Treat. 2024 Jan 31. doi: 10.1007/s10549-023-07237.
Cancer Lett
- CHEN SY, Zhang FL, Zhang YL, Liao L, et al
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of
Dicer to accelerate triple-negative breast cancer progression.
Cancer Lett. 2024 Jan 25:216672. doi: 10.1016/j.canlet.2024.216672.
- LIU C, Qian X, Yu C, Xia X, et al
Inhibition of ATM promotes PD-L1 expression by activating JNK/c-Jun/TNF-alpha
signaling axis in triple-negative breast cancer.
Cancer Lett. 2024 Jan 24:216642. doi: 10.1016/j.canlet.2024.216642.
Clin Breast Cancer
- NILSSON L, Khazaei S, Tryggvadottir H, Bjorner S, et al
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR)
Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer
Patients.
Clin Breast Cancer. 2023 Dec 21:S1526-8209(23)00306.
- MCKECHNIE T, Brown Z, Lovrics O, Yang S, et al
Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for
Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
Clin Breast Cancer. 2023 Dec 16:S1526-8209(23)00305.
- HAN J, Hua H, Fei J, Liu J, et al
Prediction of Disease-Free Survival in Breast Cancer using Deep Learning with
Ultrasound and Mammography: A Multicenter Study.
Clin Breast Cancer. 2024 Jan 17:S1526-8209(24)00006.
Discov Oncol
- TURKOGLU F, Calisir A, Ozturk B
Clinical importance of serum miRNA levels in breast cancer patients.
Discov Oncol. 2024;15:19.
- LI W, Fu Y, Sun J, Gong H, et al
Construction and in vitro evaluation of pH-sensitive nanoparticles to reverse
drug resistance of breast cancer stem cells.
Discov Oncol. 2024;15:21.
- SHEN WJ, Zhang Y
RPN1 promotes the proliferation and invasion of breast cancer cells by activating
the PI3K/AKT/mTOR signaling pathway.
Discov Oncol. 2024;15:25.
Int J Cancer
- RYBINSKA I, Mangano N, Romero-Cordoba SL, Regondi V, et al
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with
triple negative breast cancer aggressiveness.
Int J Cancer. 2024 Jan 30. doi: 10.1002/ijc.34859.
J Clin Invest
- LI Z, Metzger Filho O, Viale G, dell'Orto P, et al
HER2 heterogeneity and treatment response-associated profiles in HER2-positive
breast cancer in the NCT02326974 clinical trial.
J Clin Invest. 2024 Feb 1:e176454. doi: 10.1172/JCI176454.
J Clin Oncol
- GANZ PA, Bandos H, Spanic T, Friedman S, et al
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled
Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal
Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol. 2024 Feb 1:JCO2301214. doi: 10.1200/JCO.23.01214.
J Natl Cancer Inst
- YANGUELA J, Jackson BE, Reeder-Hayes KE, Roberson ML, et al
Simulating the population impact of interventions to reduce racial gaps in breast
cancer treatment.
J Natl Cancer Inst. 2024 Jan 27:djae019. doi: 10.1093.
J Nucl Med
- JACENE H, Dietsche E, Specht J
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer.
J Nucl Med. 2024 Feb 1:jnumed.122.264882. doi: 10.2967/jnumed.122.264882.
Lancet Oncol
- MEATTINI I, Becherini C, Caini S, Coles CE, et al
International multidisciplinary consensus on the integration of radiotherapy with
new systemic treatments for breast cancer: European Society for Radiotherapy and
Oncology (ESTRO)-endorsed recommendations.
Lancet Oncol. 2024;25:e73-e83.
NPJ Breast Cancer
- MEI J, Cai Y, Zhu H, Jiang Y, et al
High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in
triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:11.
Oncogene
- SONG H, Zhao Z, Ma L, Zhao W, et al
Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via
promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback
loop.
Oncogene. 2024 Jan 27. doi: 10.1038/s41388-024-02950.
- GARIKAPATI K, Young IC, Hong S, Rai P, et al
Blocking LBH expression causes replication stress and sensitizes triple-negative
breast cancer cells to ATR inhibitor treatment.
Oncogene. 2024 Jan 31. doi: 10.1038/s41388-024-02951.
PLoS One
- SINKALA M, Naran K, Ramamurthy D, Mungra N, et al
Machine learning and bioinformatic analyses link the cell surface receptor
transcript levels to the drug response of breast cancer cells and drug off-target
effects.
PLoS One. 2024;19:e0296511.
- PIEDRA-DELGADO L, Chambergo-Michilot D, Morante Z, Fairen C, et al
Survival according to the site of metastasis in triple-negative breast cancer
patients: The Peruvian experience.
PLoS One. 2024;19:e0293833.
Radiol Imaging Cancer
- HAVER HL, Gupta AK, Ambinder EB, Bahl M, et al
Evaluating the Use of ChatGPT to Accurately Simplify Patient-centered Information
about Breast Cancer Prevention and Screening.
Radiol Imaging Cancer. 2024;6:e230086.
- NGUYEN DL, Lotfalla M, Cimino-Mathews A, Habibi M, et al
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with
Malignant Index Breast Cancer Masses at Preoperative Breast MRI.
Radiol Imaging Cancer. 2024;6:e230060.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016